Cargando…

Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Baiqiang, Zhu, Xuan, Chen, Runzhe, Wu, Qing, Jin, Jia’nan, Wang, Lin, Xu, Yujin, Chen, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857614/
https://www.ncbi.nlm.nih.gov/pubmed/36673123
http://dx.doi.org/10.3390/diagnostics13020313
_version_ 1784873908473692160
author Dong, Baiqiang
Zhu, Xuan
Chen, Runzhe
Wu, Qing
Jin, Jia’nan
Wang, Lin
Xu, Yujin
Chen, Ming
author_facet Dong, Baiqiang
Zhu, Xuan
Chen, Runzhe
Wu, Qing
Jin, Jia’nan
Wang, Lin
Xu, Yujin
Chen, Ming
author_sort Dong, Baiqiang
collection PubMed
description Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible patients treated with SBRT from 2013 to 2018, and both serum complete blood count and blood biochemical results were available prior to (within 60 days) radiotherapy were included. Results: A review of hospital registries identified 148 patients, and the 5-year OS and PFS of the entire cohort were 69.8% and 65.6%, respectively, with the median follow-up time was 52.8 months. Multivariable analysis showed that derived neutrophil-lymphocyte ratio (dNLR) ≥1.4 and C-reactive protein (CRP) ≥2.9 were statistically and independently associated with worse OS (HR = 4.62, 95% CI 1.89–11.27, p = 0.001; HR = 2.92, 95% CI 1.49–5.70, p = 0.002, respectively). The 5-year OS for patients with dNLR below and equal to or above the 1.4 were 85.3% and 62.9% (p = 0.002), respectively, and 76.7% for the low CRP group versus 58.5% for the high CRP group (p = 0.030). Higher serum level of post-treatment CRP also independent parameters for inferior PFS (HR = 4.83, 95% CI 1.28–18.25, p = 0.020). Conclusions: Our results demonstrate that dNLR and CRP are associated with the outcomes of early-stage NSCLC patients treated with SBRT, which may assist in selecting optimal nursing care and therapeutic scheme for every individual.
format Online
Article
Text
id pubmed-9857614
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98576142023-01-21 Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy Dong, Baiqiang Zhu, Xuan Chen, Runzhe Wu, Qing Jin, Jia’nan Wang, Lin Xu, Yujin Chen, Ming Diagnostics (Basel) Article Objectives: To explore the relationship between peripheral blood inflammation parameters and overall survival (OS) and progression-free survival (PFS) of early-stage non-small cell lung cancer patients who underwent stereotactic body radiotherapy (SBRT). Patients and methods: In this study, eligible patients treated with SBRT from 2013 to 2018, and both serum complete blood count and blood biochemical results were available prior to (within 60 days) radiotherapy were included. Results: A review of hospital registries identified 148 patients, and the 5-year OS and PFS of the entire cohort were 69.8% and 65.6%, respectively, with the median follow-up time was 52.8 months. Multivariable analysis showed that derived neutrophil-lymphocyte ratio (dNLR) ≥1.4 and C-reactive protein (CRP) ≥2.9 were statistically and independently associated with worse OS (HR = 4.62, 95% CI 1.89–11.27, p = 0.001; HR = 2.92, 95% CI 1.49–5.70, p = 0.002, respectively). The 5-year OS for patients with dNLR below and equal to or above the 1.4 were 85.3% and 62.9% (p = 0.002), respectively, and 76.7% for the low CRP group versus 58.5% for the high CRP group (p = 0.030). Higher serum level of post-treatment CRP also independent parameters for inferior PFS (HR = 4.83, 95% CI 1.28–18.25, p = 0.020). Conclusions: Our results demonstrate that dNLR and CRP are associated with the outcomes of early-stage NSCLC patients treated with SBRT, which may assist in selecting optimal nursing care and therapeutic scheme for every individual. MDPI 2023-01-14 /pmc/articles/PMC9857614/ /pubmed/36673123 http://dx.doi.org/10.3390/diagnostics13020313 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dong, Baiqiang
Zhu, Xuan
Chen, Runzhe
Wu, Qing
Jin, Jia’nan
Wang, Lin
Xu, Yujin
Chen, Ming
Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title_full Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title_fullStr Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title_full_unstemmed Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title_short Derived Neutrophil-Lymphocyte Ratio and C-Reactive Protein as Prognostic Factors for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy
title_sort derived neutrophil-lymphocyte ratio and c-reactive protein as prognostic factors for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857614/
https://www.ncbi.nlm.nih.gov/pubmed/36673123
http://dx.doi.org/10.3390/diagnostics13020313
work_keys_str_mv AT dongbaiqiang derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT zhuxuan derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT chenrunzhe derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT wuqing derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT jinjianan derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT wanglin derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT xuyujin derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy
AT chenming derivedneutrophillymphocyteratioandcreactiveproteinasprognosticfactorsforearlystagenonsmallcelllungcancertreatedwithstereotacticbodyradiationtherapy